ARCHIVES

Nevins Retracts Key Paper By Duke Group, Raising Question Of Harm To Patients

This article is from The Cancer Letter archive.

Vol. 36 No. 39 | October 29, 2010

Download PDF Visit The Full Archive

Related Articles

Vanderbilt Wins Lung Cancer SPORE Grant.

May 18, 2001

ODAC Recommends Approval Of Paxen; Will IVAX Break Into $1 Billion Market

September 26, 1997

Community Cancer Control Program Survives Schmidt Criticism; NCAB Votes To Continue

October 17, 1975

In Brief: Nobel Prize Awarded To Sharp, Roberts For Gene Splicing; ACS Fills Top Positions

October 22, 1993

Pfizer Begins Phase III Trial Of Sunitinib In NSCLC

September 28, 2007

Senate Confirms FDA Commissioner Von Eschenbach.

December 8, 2006